2026
Glucagon‐Like Peptide‐1 Receptor Agonists and Cardiovascular Events in Adults With Obesity and Autoimmune Disease: A Target Trial Emulation
Journal of the American Heart Association
Publisher's siteSerena Jingchuan Guo, MD, PhD
Research at a glance
Top areas of exploration
- Diabetes Mellitus, Type 1 , 4 publications
- Diabetes Mellitus, Type 2 , 4 publications
- Analgesics, Opioid , 3 publications
- Anticoagulants , 3 publications
Research activity
My publications
Filter publications
88 publications
2026
Response to “Prepregnancy GLP ‐ 1 Receptor Agonist Use: Unaccounted Pretreatment BMI May Distort Obstetric Outcome Signals in Real‐World Studies”
Obesity
Publisher's site2026
Machine Learning Model for Predicting Suicide Risks Among Patients With Posttraumatic Stress Disorder Who Received Opioids
Depression and Anxiety
Publisher's site2026
Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1–Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop
Annals of Internal Medicine
Publisher's site2026
Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
Diabetes, Obesity and Metabolism
Publisher's site